# Subarachnoid Hemorrhage

Spontaneous subarachnoid hemorrhage requires immediate noncontrast CT, escalation to lumbar puncture when suspicion persists after negative imaging, identification and early exclusion of an aneurysm, specialized neurovascular care, and prevention of delayed cerebral ischemia with nimodipine and vigilant vasospasm surveillance. [7]

**Clinical question:** How should physicians rapidly diagnose and manage suspected spontaneous subarachnoid hemorrhage while preventing rebleeding and delayed cerebral ischemia?

Updated: 2026-08-20T23:48:59.647388Z

## What matters in practice
- In suspected spontaneous subarachnoid hemorrhage, noncontrast head CT is the initial diagnostic study; if CT is negative but clinical suspicion remains, perform lumbar puncture. [7]
- Aneurysmal subarachnoid hemorrhage should be managed in a specialized center with early aneurysm exclusion from the circulation. [7]
- Nimodipine is recommended to prevent delayed cerebral ischemia after subarachnoid hemorrhage. [7]
- Transcranial Doppler ultrasonography is useful for diagnosing and monitoring vasospasm, but clinical deterioration requires broader evaluation for delayed cerebral ischemia and alternative causes. [7]
- Hypertension and smoking are major risk factors for spontaneous aneurysmal subarachnoid hemorrhage. [7]

## Diagnose suspected subarachnoid hemorrhage without delaying definitive care

Treat a compatible presentation as a neurovascular emergency until excluded.

Obtain noncontrast head CT first in suspected spontaneous subarachnoid hemorrhage. If CT does not demonstrate hemorrhage but the clinical suspicion remains high, proceed to lumbar puncture. This sequence is identified as the diagnostic approach of choice in the supplied guideline. [7]

After subarachnoid hemorrhage is confirmed, diagnostic evaluation must identify the bleeding source, most commonly a ruptured cerebral aneurysm. The guideline identifies MRI and angiography as studies used to determine the source of hemorrhage. [7]

Diagnostic workup should proceed in parallel with stabilization and transfer planning. Patients with subarachnoid hemorrhage require care in specialized centers experienced in neurovascular diagnosis, intervention, and complication management. [7]
- Initial test: noncontrast head CT. [7]
- Persisting suspicion after negative CT: lumbar puncture. [7]
- Source evaluation after confirmation: angiography and MRI are cited diagnostic modalities. [7]
- Disposition: specialized neurovascular/stroke center care. [7]

*Diagnostic sequence for suspected spontaneous subarachnoid hemorrhage. [7]*

| Clinical state | Immediate action | Decision consequence |
| --- | --- | --- |
| Suspected spontaneous subarachnoid hemorrhage | Noncontrast head CT. [7] | Confirms hemorrhage when positive and initiates source evaluation and urgent neurovascular management. [7] |
| Negative CT with persistent clinical suspicion | Lumbar puncture. [7] | Used to evaluate for subarachnoid hemorrhage not demonstrated on CT. [7] |
| Confirmed subarachnoid hemorrhage | MRI and angiography to determine the bleeding source. [7] | Supports identification and early exclusion of a ruptured aneurysm from the circulation. [7] |

## Stabilize and secure the aneurysm early

The immediate priorities are neurologic stabilization, prevention of rebleeding, and prompt neurovascular intervention.

Subarachnoid hemorrhage is a severe, complex condition that should be managed in a specialized center. Early exclusion of an aneurysm from the circulation is recommended. [7]

Initial neurologic severity stratification informs level of care. The supplied guideline advises considering stroke-unit admission for patients with good initial clinical condition, specifically Hunt and Hess grades I or II; more severe presentations require higher-acuity monitoring and neurocritical care capability. [7]

Blood pressure treatment may be considered in the management of vasospasm, but the supplied source does not provide a general acute blood-pressure target before aneurysm exclusion. Use institutional neurovascular protocols and avoid implying a specific threshold unsupported by the available evidence. [7]
- Arrange early neurosurgical and endovascular consultation for aneurysm exclusion. [7]
- Use a specialized neurovascular center or transfer pathway when local capability is unavailable. [7]
- Use Hunt and Hess grading to communicate initial clinical condition and support disposition decisions. [7]
- Do not delay escalation of care while awaiting complete etiologic characterization. [7]

### Treatment modality selection

The supplied guideline recommends early aneurysm exclusion but does not provide source-supported comparative criteria for surgical clipping versus endovascular coiling. Procedure selection should therefore be made by the neurovascular team according to aneurysm anatomy, patient status, and local expertise rather than applying unsupported universal rules. [7]

*Early management priorities in spontaneous subarachnoid hemorrhage. [7]*

| Priority | Action | Rationale |
| --- | --- | --- |
| Appropriate setting | Manage in a specialized center. [7] | Subarachnoid hemorrhage requires experienced diagnostic, neurocritical care, and neurovascular treatment pathways. [7] |
| Prevent recurrent aneurysmal bleeding | Pursue early exclusion of the aneurysm from the circulation. [7] | Ruptured aneurysm is the most common cause of spontaneous subarachnoid hemorrhage. [7] |
| Severity communication | Document clinical grade, including Hunt and Hess status. [7] | Initial condition informs monitoring intensity and disposition. [7] |

## Prevent and monitor delayed cerebral ischemia

Delayed cerebral ischemia and vasospasm require active surveillance after aneurysm-directed treatment.

Nimodipine is recommended for prevention of delayed cerebral ischemia after subarachnoid hemorrhage. [7] The supplied literature does not provide a dosing regimen, route, duration, contraindications, or monitoring parameters; use current institutional protocols and product labeling for these details.

Transcranial Doppler ultrasonography is useful for diagnosing and monitoring vasospasm. [7] It should be interpreted in the clinical context rather than treated as a stand-alone determinant of cerebral ischemia.

For established or refractory vasospasm, the guideline states that blood pressure treatment and neurovascular intervention may be considered. [7] The source does not specify an induced-hypertension target, endovascular technique, or intervention threshold; these decisions require individualized neurocritical care and neurointerventional assessment.
- Administer nimodipine for delayed cerebral ischemia prevention. [7]
- Monitor for vasospasm with transcranial Doppler ultrasonography. [7]
- Evaluate new focal deficits or reduced consciousness urgently for delayed cerebral ischemia, vasospasm, rebleeding, hydrocephalus, seizure, metabolic derangement, and nonneurologic critical illness; the supplied source specifically supports Doppler monitoring for vasospasm but does not provide a complete differential algorithm. [7]
- Consider blood pressure treatment and neurovascular intervention for refractory vasospasm according to specialist assessment. [7]

*Monitoring and escalation for vasospasm and delayed cerebral ischemia after subarachnoid hemorrhage. [7]*

| Problem | Supported monitoring or treatment | Important limitation |
| --- | --- | --- |
| Delayed cerebral ischemia prevention | Nimodipine is recommended. [7] | No source-supported dose or duration is available in the supplied literature. |
| Vasospasm surveillance | Transcranial Doppler ultrasonography is useful for diagnosis and monitoring. [7] | Doppler findings require correlation with examination and other clinical data. |
| Refractory vasospasm | Blood pressure treatment and neurovascular intervention may be considered. [7] | No specific target or procedural selection criteria are provided in the supplied source. |

## Frame risk, prognosis, and prevention around modifiable factors

Risk-factor modification matters, but acute prognosis is driven chiefly by hemorrhage severity and complications.

Rupture of a cerebral aneurysm is the most common cause of spontaneous subarachnoid hemorrhage. Hypertension and smoking are identified as the principal risk factors. [7] These factors should be addressed in long-term prevention discussions after stabilization.

Clinical condition at presentation is central to prognosis and care intensity. The supplied guideline uses Hunt and Hess grades I and II to identify patients with good initial clinical condition who may be considered for stroke-unit admission. [7] It does not provide source-supported mortality estimates, rebleeding probabilities, or validated treatment-specific prognostic thresholds.

Avoid overinterpreting hemorrhage severity from a single variable. The available source supports clinical grading and specialized-center care but does not provide a complete prognostic model or a specific framework for goals-of-care decisions. [7]
- Address smoking cessation and hypertension management during recovery and secondary prevention planning. [7]
- Use initial neurologic grade to communicate severity, allocate monitoring resources, and structure prognostic discussions. [7]
- Explain that aneurysm-directed treatment and delayed ischemia prevention remain time-sensitive even in initially good-grade disease. [7]

*Risk and prognostic factors supported by the supplied literature. [7]*

| Factor | Clinical implication |
| --- | --- |
| Hypertension | Major risk factor for spontaneous subarachnoid hemorrhage; address as part of long-term prevention. [7] |
| Smoking | Major risk factor for spontaneous subarachnoid hemorrhage; cessation counseling is clinically relevant after stabilization. [7] |
| Initial Hunt and Hess clinical condition | Supports acuity stratification and disposition planning; grades I–II are described as good initial clinical condition. [7] |

## Use a protocolized multidisciplinary pathway

Time-sensitive diagnosis, aneurysm treatment, and complication surveillance depend on coordinated systems.

The supplied guideline emphasizes care in specialized centers and early aneurysm exclusion. [7] A practical U.S. pathway should therefore include emergency medicine, neurology, neurosurgery, neurointerventional specialists, anesthesia, neurocritical care, and transfer coordination when local definitive treatment is unavailable.

Use structured handoffs that include time of symptom onset, neurologic examination, CT result, lumbar-puncture result when obtained, hemodynamic trajectory, antithrombotic exposure, and timing of neurovascular consultation. These elements are operationally important, although specific handoff content is not prescribed in the supplied literature.
- Activate transfer early if angiography, aneurysm treatment, neurocritical care, or endovascular rescue capability is unavailable. [7]
- Ensure the receiving center can provide early aneurysm exclusion and monitoring for vasospasm and delayed cerebral ischemia. [7]
- Embed transcranial Doppler capability within the post-hemorrhage surveillance pathway when available. [7]

*Core components of a subarachnoid hemorrhage care pathway. [7]*

| Phase | System requirement |
| --- | --- |
| Diagnosis | Immediate noncontrast CT and lumbar puncture when CT is negative but suspicion persists. [7] |
| Etiologic evaluation | Access to angiography and neurovascular expertise to identify the bleeding source. [7] |
| Definitive treatment | Early aneurysm exclusion at a specialized center. [7] |
| Post-treatment surveillance | Nimodipine use and transcranial Doppler monitoring for delayed cerebral ischemia and vasospasm. [7] |

## Common questions

### What should follow a negative noncontrast CT when suspicion for subarachnoid hemorrhage remains high?

Perform lumbar puncture when CT is negative but clinical suspicion for subarachnoid hemorrhage persists. [7]

### What medication is recommended to prevent delayed cerebral ischemia after subarachnoid hemorrhage?

Nimodipine is recommended for prevention of delayed cerebral ischemia. The supplied source does not provide dosing details. [7]

### How should vasospasm be monitored after subarachnoid hemorrhage?

Transcranial Doppler ultrasonography is useful for diagnosing and monitoring vasospasm. [7]

### Where should patients with aneurysmal subarachnoid hemorrhage be treated?

Manage patients in a specialized center capable of early aneurysm exclusion and neurovascular complication management. [7]

## References
1. UK guidelines on the management of variceal ... — gut.bmj.com — https://gut.bmj.com/content/64/11/1680
2. A Pooled Analysis of INTERACT2 and ATACH II — www.ahajournals.org — https://www.ahajournals.org/doi/10.1161/JAHA.125.049096
3. Cerebral Hemorrhage: Pathophysiology, Treatment, and ... — www.ahajournals.org — https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.121.319949
4. Volume Tolerance and Prognostic Impact of Hematoma ... — www.ahajournals.org — https://www.ahajournals.org/doi/10.1161/STROKEAHA.124.049008
5. 2022 Guideline for the Management of Patients With ... — www.ahajournals.org — https://www.ahajournals.org/doi/10.1161/STR.0000000000000407
6. FDA-approved heterocyclic molecules for cancer treatment — www.cell.com — https://www.cell.com/heliyon/fulltext/S2405-8440(23)10380-X
7. Clinical management guidelines for subarachnoid haemorrhage. Diagnosis and treatment — www.sciencedirect.com — https://www.sciencedirect.com/science/article/pii/S2173580814000819
8. Control of Hemorrhage - an overview — www.sciencedirect.com — https://www.sciencedirect.com/topics/medicine-and-dentistry/control-of-hemorrhage
9. Perioperative management of brain hemorrhage: Advances in anesthetic strategies and translational medicine — www.sciencedirect.com — https://www.sciencedirect.com/science/article/pii/S2589238X25000555
10. Management of Intracerebral Hemorrhage: JACC Focus ... — www.sciencedirect.com — https://www.sciencedirect.com/science/article/pii/S0735109720344922
11. The FDA's Generic-Drug Approval Process:... : American Journal of Gastroenterology — journals.lww.com — https://journals.lww.com/ajg/fulltext/10.1038/ajg.2011.29~the-fdas-generic-drug-approval-process-similarities-to-and
12. Prescribing patterns of target-specific oral... : Blood Coagulation & Fibrinolysis — journals.lww.com — https://journals.lww.com/bloodcoagulation/fulltext/2015/10000/prescribing_patterns_of_target_specific_oral.9.aspx
13. Stop the bleed “ – Prehospital bleeding control in patients with multiple and/or severe injuries – A systematic review and clinical practice guideline – A systematic review and clinical practice guideline — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC11799122
14. Management of obstetric and gynecologic hemorrhage: a narrative review of current guidelines and evidence — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC13155169
15. Nonsurgical management of major hemorrhage - PMC — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC10241541
16. National and International Guidelines for Patient Blood Management in Obstetrics: A Qualitative Review — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC5161642
17. Clinical guideline highlights for the hospitalist — pubmed.ncbi.nlm.nih.gov — https://pubmed.ncbi.nlm.nih.gov/36725674
18. a guideline for healthcare professionals from the ... - PubMed — pubmed.ncbi.nlm.nih.gov — https://pubmed.ncbi.nlm.nih.gov/20651276
19. Control of haemorrhage in hospital - Major Trauma: Assessment and Initial Management - NCBI Bookshelf — www.ncbi.nlm.nih.gov — https://www.ncbi.nlm.nih.gov/books/NBK368079
20. Executive Summary - Prehospital Emergency Medical Services Blood Transfusion and Fluid Interventions for Hemorrhagic Shock - NCBI Bookshelf — www.ncbi.nlm.nih.gov — https://www.ncbi.nlm.nih.gov/books/NBK621890
21. Hemorrhage Control - StatPearls - NCBI Bookshelf — www.ncbi.nlm.nih.gov — https://www.ncbi.nlm.nih.gov/sites/books/NBK535393
22. Recommendations and supporting evidence - Consolidated guidelines for the prevention, diagnosis and treatment of postpartum haemorrhage - NCBI Bookshelf — www.ncbi.nlm.nih.gov — https://www.ncbi.nlm.nih.gov/books/NBK619233
23. Alternatives to the Kleihauer Betke test: diagnostic performance of three methods in the detection of feto-maternal hemorrhage — www.ajog.org — https://www.ajog.org/article/S0002-9378(03)01415-7/fulltext
24. Investigation of Acute Idiopathic Pulmonary Hemorrhage ... — www.cdc.gov — https://www.cdc.gov/mmwr/preview/mmwrhtml/mm5335a4.htm

## Editorial note

Prepared from cited clinical literature using Astra's research workflow. Verify recommendations against current guidance and patient-specific factors.